Urbanucci et al., showed that castration-resistant prostate cancer (CRPC) had chromatin accessibility which may drive cancer progression and AR/androgen -regulated BRDs including ATAD2 mediated this effect20. The gene discussed is ATAD2; the disease is cancer.